SANDECKÁ, Viera, Zdeněk ADAM, Marta KREJČÍ, Martin ŠTORK, Zdeněk ŘEHÁK, Renata KOUKALOVÁ, Sabina ŠEVČÍKOVÁ, Lucie BROŽOVÁ, Zdeněk KRÁL, Jiří MAYER and Luděk POUR. Diagnostic relevance of 18F-FDG PET/CT in newly diagnosed patients with monoclonal gammopathy of undetermined significance (MGUS): Single-center experience. Neoplasma. Bratislava: Slovenská akademie vied, 2020, vol. 67, No 4, p. 939-945. ISSN 0028-2685. Available from: https://dx.doi.org/10.4149/neo_2020_191104N1137.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Diagnostic relevance of 18F-FDG PET/CT in newly diagnosed patients with monoclonal gammopathy of undetermined significance (MGUS): Single-center experience
Authors SANDECKÁ, Viera (703 Slovakia), Zdeněk ADAM (203 Czech Republic), Marta KREJČÍ (203 Czech Republic), Martin ŠTORK (203 Czech Republic, guarantor), Zdeněk ŘEHÁK (203 Czech Republic), Renata KOUKALOVÁ (203 Czech Republic), Sabina ŠEVČÍKOVÁ (203 Czech Republic, belonging to the institution), Lucie BROŽOVÁ (203 Czech Republic, belonging to the institution), Zdeněk KRÁL (203 Czech Republic), Jiří MAYER (203 Czech Republic) and Luděk POUR (203 Czech Republic).
Edition Neoplasma, Bratislava, Slovenská akademie vied, 2020, 0028-2685.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher Slovakia
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.575
RIV identification code RIV/00216224:14110/20:00116304
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.4149/neo_2020_191104N1137
UT WoS 000557901000025
Keywords in English monoclonal gammopathy; cancer; multiple myeloma; PET/CT
Tags 14110518, 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 1/9/2020 09:08.
Abstract
Monoclonal gammopathy of undetermined significance (MGUS) is a known precursor of more serious cancers, such as multiple myeloma (MM), Waldenstrom macroglobulinemia (MW) and other lymphoproliferative disorders. Using 18F-FDG PET/CT, we aimed to evaluate its benefit in early detection of various accompanying disorders and illnesses in MGUS patients. We prospectively analyzed the diagnostic relevance of 18F-FDG PET/CT in 390 newly diagnosed MGUS patients. On 18F-FDG PET/CT scans, the presence of focal or diffuse areas of detectable increased tracer uptake was recorded in 37 (9.5%) MGUS patients. The most frequent pathology was lymphadenopathy (3.8%), followed by thyroid diseases (2.1%), rheumatic diseases (1.8%), and other solid malignancies (1.5%). These results have major implications for confirmed associations of MGUS with numerous malignant and non-malignant disorders. We believe that 18F-FDG PET/CT imaging in newly diagnosed MGUS patients may be useful in early detection of other serious pathologies, not only in predicting progression of MGUS to active MM, and should be strongly recommended if available.
PrintDisplayed: 26/5/2024 06:07